- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05706961
Power Walking On Quality Of Life In Post CABG Patient Undergoing Phase 2 Cardiac Rehabilitation
Effect Of Power Walking On Quality Of Life In Post CABG Patient Undergoing Phase 2 Cardiac Rehabilitation
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Khyber PkahtoonKhwa
-
Abbottābād, Khyber PkahtoonKhwa, Pakistan, 22010
- Women Institute of Rehabilitation Sciences (WIRS) and Jinnah International Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male and Female subject
- Age will be from 50 to 70
- Four weeks after CABG surgery patient are eligible to participate
- Patient able to walk on Treadmill with Cardiac symptoms stable or absent
- Appropriate HR response to exercise
Exclusion Criteria:
- Those patients with contraindications to exercise or clinical risk factors, such as musculoskeletal, neurological, pulmonary or metabolic disorder were all excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Power Walking
|
For 1- 2 Week 60% of the target heart rate with 5,000 to 7,500 steps/day Total 30 min Session The exercise intensity was set at 60% of the target heart rate during the first 2 weeks. For 3- 4 week 70 % of the target heart rate with 7,500 to 10,000 steps/day Total 30 min Session B) Progressive increase walk according to 6MWD as improved Low intensity |
Active Comparator: Standardized Outpatient Cardiac Rehabilitation
|
For 1- 2 week Standardized Outpatient Cardiac Rehabilitation (includes warm up of 5 min, aerobic 60 % of of target heart rate, resistive ex with 1- 3 kg of weight for 20 min and 10 min of cool down) For 3 - 4 week Standardized Outpatient Cardiac Rehabilitation (includes warm up of 5 min, aerobic 70 % of target heart rate, resistive ex with 2- 3 kg of weight for 20 min and 10 min of cool down) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart Quality of Life questionnaire
Time Frame: 4th weeks
|
Changes from baseline to 4 week, The 14 items in the HeartQoL scale form a bi-dimensional questionnaire with a 10-item HeartQoL physical subscale and a 4-item HeartQoL emotional subscale that provides a global assessment and evaluation of how much a patient with angina, MI, or heart fail.
|
4th weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Six Minute Walk Test (6MWT)
Time Frame: 4th week
|
Changes from baseline to 4 week, The 6MWT can be used in preschool children (2-5 years), children (6-12 years) adults (18-64 years), elderly adults (65+) with a wide range of diagnoses including.
The test was initially designed to help in the assessment of patient with cardiopulmonary is
|
4th week
|
BORG Rating of Perceived exertion
Time Frame: 4th Week
|
Changes from baseline to 4 week, The Borg RPE Scale is a 15-point scale (6 to 20) used to rate subjective experiences during physical exertion.
This subjective load scale can help estimate load symptoms, such as the degree of exertion, the degree of load and fatigue.
The Borg scale among
|
4th Week
|
Pulse rate
Time Frame: 4th Week
|
Changes from baseline to 4 week, Pulse rate will be measured through the Pulse Oximeter in beats per min before and after the exercise for the patient safety during exercise
|
4th Week
|
Liebowitz Social Anxiety Scale
Time Frame: 4th Week
|
Changes from baseline to 4 week, The LSAS is a 24-item scale that assesses fear of social situations and avoidance throughout the previous week.
It includes 11 things that deal with social contact and 13 ones that deal with public performance.
A physician rates each item on two 4-point L
|
4th Week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Muhammad Iqbal Tariq, PhD*, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/01374 Awais Ahmed
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Power Walking
-
Gulf Medical UniversityCompletedCoronary Artery Disease | Coronary Disease | Coronary Arteriosclerosis | Coronary Syndrome | Heart Diseases, IschemicUnited Arab Emirates
-
University of OklahomaU.S. Department of EducationCompletedCerebral Palsy | Child, PreschoolUnited States
-
Youngstown State UniversityCompleted
-
Nova Southeastern UniversityJohn H. Stroger HospitalCompletedRisk Reduction | Unsafe SexUnited States
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Bezmialem Vakif UniversityCompleted
-
McMaster UniversityRecruiting
-
Assiut UniversityNot yet recruiting
-
Liberating Technologies, Inc.Hanger Clinic: Prosthetics & OrthoticsRecruitingLower Limb Amputation Above Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation; Traumatic, Leg: Thigh, Between Hip and KneeUnited States
-
Beijing Chao Yang HospitalPeking University First Hospital; Guang'anmen Hospital of China Academy of... and other collaboratorsUnknownInflammation | COPDChina